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ABSTRAK
Diabetes melitus (DM) adalah masalah kesehatan yang paling penuh dengan tantangan dan dipercaya 
merupakan hasil antara interaksi gen dan paparan lingkungan. Terdapat hipotesis mekanisme epigenetik, 
menggunakan dasar molekular untuk menjelaskan mekanisme terjadinya DM. Karena paparan lingkungan 
termasuk status gizi dan keadaan hiperglikemia, risiko terjadinya DM telah dimulai sejak pre-konsepsi, yang 
berlangsung hingga dewasa, dan diwariskan antar-generasi. Terdapat 3 mekanisme utama epigenetik yang 
berperan pada DM. Mekanisme-mekanisme epigenetik juga memiliki peran dalam memori metabolik dimana 
komplikasi-komplikasi DM dapat tetap terjadi walaupun kadar gula darah dalam tubuh sudah normal. 
Pembatasan kalori dapat membantu menunda proses dan terjadinya penyakit-penyakit degeneratif termasuk 
DM dengan cara menstabilkan genom melalui mekanisme-mekanisme epigenetik.
Kata kunci: diabetes, mekanisme epigenetik, memori metabolik.
ABSTRACT
Diabetes mellitus (DM) is one of the most abundant diseases in the 21st century and believed as result of 
interaction between genes and environment exposure. There is a hypotesis of epigenetic mechanisms, using 
molecular basis to explain about the mechanism of DM. Because of the enviromental exposure including nutrition 
status and hyperglycemia state, the risk of DM has started since pre-conception, last until adulthood and will 
be inhireted trans-generational . Mainly, there are 3 epigenetic mechanisms that have role in DM. Epigenetic 
mechanisms are also have role in the metabolic memory that the DM complications may still developed although 
the blood glucose level is already normal. The restriction of calory intake may help delaying the development 
and onset of degerative diseases including DM by stabilizing genome through epigenetic mechanisms.
Keywords: diabetes, epigenetic mechanisms, metabolic memory.
INTRODUCTION
Diabetes mellitus (DM) is one of the 
abundant diseases in the 21st century. The 
approximated prevalence of DM among adults in 
the world was 366 million in 2011, and in 2030 
this will become 552 million.1 DM is a disease 
caused by metabolic dysregulation, marked by 
chronic high blood glucose level causing many 
complications that may reduce life expectancy 
and quality of life. The disease mechanism of 
DM is not well understood until now, but it is 
known that it is the result of interaction between 
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genes and environment exposure.1,2
There is a hypothesis regarding epigenetic 
mechanisms explaining the association between 
imbalanced nutrition and altered disease risk, 
using molecular basis to explain the link between 
perinatal nutrition intake and degenerative 
diseases, including DM.2 The classical definition of 
epigenetic was first stated by Conrad Waddington 
in the 1950s, that mentioned the epigenetic trait as 
a stable phenotype changes that may be inherited, 
as the result from changes in chromosomes but 
with no alternation in DNA sequence.3 Through 
epigenetics, the organism can alter its pattern of 
development to cope with environment stress, 
and this may pass intergenerationally as the 
accumulation of epigenetic modifications.4
INFLUENCES OF PRE-CONCEPTION, PRE-
NATAL, AND POST-NATAL NUTRITIONAL 
EXPOSSURES AS RISK OF DIABETES 
MELLITUS TO THE OFFSPRINGS
Early  l i fe  exposures  br ing a  long 
period of life increased the risks for DM, 
and may cause persistent changes including 
metabolism. Intrauterine malnutrition influences 
organogenesis, which has bad effects on organ 
morphology and function.5 The period of 
embriogenic development has been known as a 
critical window in establishing the epigenome.6
The exposures may cause trans-generationally 
inherited traits and epigenetic modifications. 
Trans-generational has a meaning that the the 
changes in phenotype must last for at least 
3 generations after the first exposure.7 The 
inheritance mechanism may happen through 
mother or father (P0). A pregnant woman (P0) can 
carry genetic and epigenetic information until F2 
generation. Her fetus (F1) and its germ cell (F2) 
may be affected by enviromental expossures. The 
changes in F1 phenotype or epigenetic state to 
be considered trans-generational if it lasts until 
F3 generation. In males (P0), the expossure may 
change his germ cells (F1), but since the F2 
germ cells are not expossed, every phenotype 
or epigenetic changes in F2 are defined as trans-
generational.7,8
Paternal’s nutrition intake can influence 
offspring’s risk of diseases through sperm 
epigenome which is included heritable 
informations, like: DNA methylation. Paternal 
obesity has relationship with changes in sperm 
numbers, concentration, motility, morphology, 
and result in sperm DNA damage.8 The paternal 
impaired fasting glucose and glucose intolerance, 
as manfifestation of pre-diabetes, will alter 
gene expression patterns in pancreatic islets, 
by downregulating several genes involved 
in glucose metaboism and insulin signaling 
pathway. It is hypothesized that nutrition 
supply as methyl donor may alter epigenetic 
reprogramming in sperm.9
Maternal pregnant obesity in combination 
with gestational DM may lead to newborn with 
hyperinsulinemia state and increased offspring’s 
fat mass until the 6th week, and this is strongly 
suggest as an important influence of gestational 
DM to the offsprings. Maternal obesity during 
pregnancy will become a serious danger to 
offsprings in adulthood. It will start trascriptional 
programs that may increase the expression of 
inflammatory molecules and immune cells, which 
reflect the epigenetic proccess. Hyperinsulinemia 
state in response to maternal obesity is mediated 
by the Insulin Receptor Substrate-1 (IRS-1), 
which is regulated by epigenetic mechanism 
through short noncoding miRNA-126.9,10
Maternal nutritional deficiency or famine may 
also give influence to the offspring depending on 
the timing of their prenatal exposures. During the 
Dutch famine in the years 1944 until 1945, those 
who were concieved in the midst of famine had 
shown to have hypomethylation at CpG (Cytosine-
phopshate-Guanine) islands inside important 
promoter site and it still can be observed until 
even 60 years later.11 The intrauterine condition 
with poor nutrition will epigenetically program the 
offsprings to survive in a low nutritional postnatal 
environment, revealing ‘catch-up growth’ in 
postnatal period, and when they are exposed to 
nutrition which are high in energy, they will have 
obesity as a cause of insulin resistance state.12
EPIGENETIC MECHANISMS TO DEVELOP 
DIABETES MELLITUS
The epigenetic mechanisms are primarily 
occuring through three mechanisms. There are: 
DNA methylation, post-translational histone 
modification, and miRNA expression.4
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DNA Methylation
The adult somatic cells consist of one haploid 
set of chromosome, which is inherited half from 
mother and the other half from father. Epigenetic 
patterns are at first deleted and reprogrammed two 
times to correct the imprinting sites with allele-
specific methylation, to form tissue specific gene 
methylation pattern in postnatal periode. The 1st 
phase of deleting and reprogramming happened 
during gametogenesis. The DNA methylation is 
deleted and later reestablished by taking specific 
imprints in oocytes and in spermatozoa. The 2nd 
phase of epigenetic deleting and reprogramming 
happened during pre-implantation. During this 
proccess, the genome with possible exception 
of imprinted genes and some retrotransposons, 
is now demethylated. The DNA methylation is 
restored after implantation, and then forming cell 
descent specific patterns in rapid way to oversee 
its differentiation.13 (Figure 1)
The DNA methylation is defined as the 
attachment a of methyl group to a cytosine (C) 
nucleotide at position 5 (5mC) and specifically 
happened when a cytosine’s position is next to 
guanine and joined by phosphate in DNA, which 
is called by CpG dinucleotide. The regions of 
genome consists lots of CpG dinucleotide are 
called by CpG islands.13 The frequent epigenetic 
Figure 1. Exposure throughout steps of life and the epigenetic dysregulation. 
Environmental exposures may cause epigenetic changes, increasing the risk of diseases 
including DM. These changes are heritable to the offsprings.13
Figure 2. Landmark of regulatory regions and histone. The DNA 
methylation may take place at the CpG islands in the promoter region. 
An illustration of histones that consist of 4 types of histone with its tail.5
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modification of DNA is in the demethylated 
CpG islands in promoter region. The promoter 
methylation during development and diseases 
proccess is related to gene trancriptional silencing.5 
(Figure 2)
The specific methylation of CpG dinucleotides 
in tissue is performed by DNA methyltransferase 
or DNMTs (1,3a,3b, and 3B) that has activity in 
de novo methylation (except for DNMT1 that has 
function to maintance the methylation of CpG), 
making the covalent binding of methyl group to 
form 5mC.13,14 The demethylation proccess starts 
by the ten-eleven translocation methylcytosine 
dioxygenase1 (TET1), which is then oxydized 
5mC to form 5-hydroxymethycytosine 
(5hmC),then into 5-formylcytosine (5fC), 
and then into 5-carboxylcytosin (5aC). The 
5mC, 5hmC, 5fC, and 5aC may have passive 
demethylation to form C. The 5f and 5aC can be 
cut by thymine-DNA glycosylase (TDG), then 
followed by DNA repair (base excision repair or 
BER) to form C. As an alternative, the 5aC may 
react with decarboxylase to form C. The 5mC can 
be deaminated by activation-induced deaminase 
(AID)/apolipoprotein B mRNA editing complex 
(APOBEC) to become 5-hydroxymethyl Urasil 
(5hmU) then exicised by TDG or methyl-CpG-
binding domain protein 4 (MBD4), and at the 
last followed by DNA repair to form C again.14 
(Figure 3)
The hyperglycemia state may induce global 
demethylation at all genomic loci including the 
promoter, intergenic, and intragenic sites. The 
most methylated CpG sites of diabetic islets 
show decrease in methylation.15 This may be 
caused by the reduction of activity of DNMT1 
during cell proliferation or a reduction in the 
activity of DNMT3a and 3b which responsible 
for methylation. There is also an increase in 
the action of Growth arrest and DNA-damage-
inducible protein GADD45A (GADD45A) 
which may also cause demethylation in human 
pancreatic cells. These changes are risk factor for 
DM. Another explaination for hypomethylation 
in hyperglycemia state is due to the decrease 
in methyl donor.16,17 The hyperglycemia state 
that may induce global demethylation is largely 
maintain in the metabolic memory state.15 (Table 
1)
Post-translational Histone Modifications
Histones (H1, H2A, H2B, H3, and H4) 
are globular protein which exist around DNA, 
packed to form chromatin. Post-translational 
histone conformational changes may happen 
Figure 3. Model of DNA demethylation pathways initiated by TET. An illustration of the 
enzymatic changes among C, 5mC, 5hmC, 5fC, and 5aC.14
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as the result of enzymes that modify lysine 
and arginine residues in amino terminus. The 
modifications are mainly acetylation and 
methylation. The acetylation may increase 
DNA accessability,meanwhile the methylation 
may result in either increased or decreased 
of DNA accessability, depend on the type of 
methylationing and histone.14,18
The histone methylations may happen at the 
lysine residue using SET- and non-SET domain 
histone lysine methyltransferase (HMTase) that 
regulates transcription and repair; and at arginine 
residue using protein arginine methyltransferase 
(PRMT) or coactivator-associated arginine 
methyltransferase1 (CARM1) that regulates 
transcription. The demethylation proccess may 
happen using lysine specific demethylase1 
(LSD1). The acetylation may happen by 
using histone acetyl transferase (HAT) that 
regulates transcription, repair, replication, and 
condensation; and the deacetylation proccess 
using histone deacetylase (HDAC).18-20 The 
active genes can be methylated at H3K4, H3K36, 
and H3K79, and the silenced or repressed genes 
are methylated at H3K9, H3K27, and H4K20.21 
The reversible acetylation of N-terminal lysine 
residues are at positions 9,14,18, and 23 of H3 
and at 5,8,12, and 16 of H4. These reversible 
acetylation can mediate the decondensation of 
nucleosome structure, alters the link between 
histone and DNA, and also may give access for 
the binding of transcription factors.18
The miRNA Expression
The miRNA may work by blocking and 
altering the genes expression.4 The target of 
miRNA is the gene promoter, through the 
recruitment of specific argonaute proteins to 
form epigenetic remodeling complexes. It can 
reduce gene expression by keeping histone 
deacetylation, histone methylation (H3K9 and 
H3K27), and DNA methylation.22 The miRNA 
can bind to 3’untranslated region of target 
mRNA, reveling in degradation or inhibit protein 
translation.4
In the nucleus, RNA polymerase II is 
transforming miRNA to form long segmens of 
coding or noncoding RNA (pri-miRNA,consist 
of 70-100 nucleotides) which are covered up and 
polyadenylated, then captured and also extracted 
by a complex consists of RNase type III, drosha, 
and dsRNA binding protein, DiGeorge syndrome 
critical region gene 8 (DGCR8)’ to form pre-
miRNA, then to form a complex with exportin5 
and RanGTP, and then it is translocated to 
cytoplasm. The dicer in cytoplasm can cleave 
the pre-miRNAs near hairpin loop to produce 
a short ~22 base pair long imperfect RNA 
duplexes. This short imperfect RNA dupleces are 
further added into mature RNA-induced silencer 
complex (mature RISC or MiRISC), and has a 
role as a template for capturing target mRNAs. 
The MiRISC can rend the target mRNAs through 
catalytic domain (RNA III domain) of argonaute 
protein (as the core component of RISC complex) 
and then degradating them.23 The MiRISC may 
also prevent protein translation through several 
different mechanisms. These mechanisms are 
including the inhibition of trancription at level 
Table 1. Genes with expressions on metabolic process 
which are related to obesity and type 2 DM
Metabolic 
process Genes
Epigenetic 
mechanisms
Adipogenesis CEBPA Histone aceylation and 
methylation
PPARA DNA methylation
Appetite regulation LEP DNA methylation
MC4R DNA methylation
NPY DNA methylation
POMC DNA methylation and 
histone
Acetylation and 
methylation
Body weight 
homeostatis
FTO DNA methylation
Glucose 
homeostasis
ADIPOQ DNA methylation and 
histone acetylation
GLUT4 DNA methylation and 
histone acetylation
INS DNA methylation and 
histone acetylation
Hypoxia HIF1A DNA methylation and 
histone
Acetylation and 
methylation
Inflammation IFNG DNA methylation
TNF DNA methylation
Lipid storage FASN DNA methylation
Stress NR3C1 Histone acetylation
Thermogenesis UCP1 DNA methylation
These genes which have expressions on metabolic 
process that controlled by epigenetic mechanisms.
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of initiation and elongation, and the degradation 
of mRNA or the immature protein products 
of mRNA. The immature protein products 
of RNA are then segregated into P bodies to 
make inhibition of translational proccess and or 
deadenylation of mRNA. The final result is the 
destabilization of mRNA.24
The exposure of islet cells to palmitate can 
cause the increament of miR-34a and miR-146 
which activate p53 and reduce vesicle-associated 
membrane protein 2. These proccess may lead to 
islet cells apoptosis and the reduction of insulin 
secretion. The exposure of proinflammatory 
cytokines to islet cells can activate miR-21,miR-
34a, and miR-146, that may also lead to the 
reduction of insulin secretion and the increament 
of the apoptosis of the cells. The upregulated 
miR-29a and -29b in insulin target organs under 
hyperglycemic state may reduce insulin mediated 
glucose uptake.25 (Table 2)
reactive oxygen species (ROS) production.26
Hyperglycemia state can reduced the 
activity of sirtuin1 (SIRT1) that can lead to the 
acetylation of p53, nuclear factor-kappa beta 
(NF-κβ) subunit p65, and histone 3 bound to 
p66shc promoter. The activation of p53 can lead 
to the increament of p66shc transcription. The 
reduction in the role of hyperglycemia state-
induced GCN (an acetyltransferase) can cause 
the acetylation of H3 and the subsequent p66shc 
transcription through chromatin remodeling. 
The p53 protein that upregulates the p66shc can 
lead to the persistence of mitochondrial ROS 
production. The high ROS production may 
result in the endothelial dysfunction, vascular 
inflammation, and apoptosis proccess of cells.27 
Moreover, the high production of ROS may 
reduce the signalling proccess from insulin 
receptor substrate1 (IRS1) to phosphatidyl 
inositol 3 kinase (PI3K), and also activates c-jun 
N-terminal kinase that translocate pancreatic and 
duodenal homeobox-1 (PDX-1) from nucleus 
to cytoplasm and induces the degradation of 
mafA, resulting in the decreased of insulin 
gene expression,insulin production, and insulin 
secretion.28,29
Restriction of calory intake has already 
shown to give a positive correlation with 
disease prevention. This restriction may increase 
lifespan and delay cardiovascular disease, DM, 
and cancer, through chromatin remodeling 
which lead to increase in age and lifespan, and 
delaying the onset of degenerative diseases 
by stabilization of genome through epigenetic 
mechanisms.9
CONCLUSION
Diabetes mellitus is a metabolic disease 
characterized by high blood glucose levels, as the 
result of genes and environmental interaction. It 
is now accepted about the concept of epigenetic 
mechanisms by molecular basis to explain 
the development of DM. There are 3 main 
epigenetic mechanisms: DNA methylation, 
post-translational histone modification, and 
micro RNA (miRNA) expression. The epigenetic 
changes on the metabolic status are already there 
since pre-conception depending on the maternal 
and paternal epigenetic changes, and it will last 
Table 2. The miRNA targets in type 2 DM
mRNA Target Function
miR-375 Myotrophin Inhibition of insulin 
secretion
miR-9 OneCut2 
transcription factor
Inhibition of glucose-
stimulated insulin 
release
miR-192 E-box repressor TGFb-induced matrix 
protein collagen col 
a-1 and -2
miR-143 GLUT4, HSL, fatty 
acid-binding protein 
aP2, PPAR-m2
Adipocyte 
differentiation
METABOLIC MEMORY
The long-(heritable) or short-acting (non 
heritable) environmental exposure may result 
in long- or short-term epigenetic changes.26 
The Diabetes Control and Complications 
Trial (DCCT) and Epidemiology of Diabetes 
Intervention and Complications (EDIC) come 
with a conclusion that in DM patients who had 
improved glycemic control may still developed 
complications as result of prior poor glycemic 
control.20 In 1990, Roy and colleagues had 
described the mechanism as metabolic memory, 
which is defined as epigenetic changes caused 
by hyperglycemia state-induced mitochondrial 
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until adulthood, and the epigenetic changes will 
be inherited trans-generational. The epigenetic 
mechanisms are also involved in the metabolic 
memory, the condition where the complications 
of DM may still happen although the blood sugar 
level is already normal. Calories restriction may 
be benefit on delaying the development and onset 
of degenerative diseases including DM through 
epigenetic mechanisms to stabilize the genome.
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